Molecular Partners broadens agreement with J&J

Thursday 8 December 2011

Privately-owned Molecular Partners AG of Switzerland has expanded its relationship with Johnson & Johnson Inc with an agreement to research potential products for a number of immunological diseases using its protein technology.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland